Clinical Trials Browser

Interventional × dapagliflozin × 30 days × Clear all

NCT07018622 2026-03-11

DAPA-ARMOR

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07436663 2026-02-27

SGLT2i/DPPi

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07235280 2026-02-19

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Phase EARLY_PHASE1 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms